Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco

Albert Liu; Stephanie Cohen; Stephen Follansbee; Deborah Cohan; Shannon Weber; Darpun Sachdev; Susan Buchbinder

doi:10.1371/journal.pmed.1001613

Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco

PLoS Med. 2014 Mar 4;11(3):e1001613. doi: 10.1371/journal.pmed.1001613. eCollection 2014 Mar.

Authors

Albert Liu¹, Stephanie Cohen², Stephen Follansbee³, Deborah Cohan⁴, Shannon Weber⁵, Darpun Sachdev¹, Susan Buchbinder⁶

Affiliations

¹ Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America.
² Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America; STD Prevention and Control, San Francisco Department of Public Health, San Francisco, California, United States of America.
³ Kaiser Permanente Medical Center, San Francisco, California, United States of America.
⁴ Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California, United States of America.
⁵ Department of Family and Community Medicine, University of California, San Francisco, San Francisco, California, United States of America.
⁶ Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America; Department of Medicine, University of California, San Francisco, San Francisco, California, United States of America; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America.

Abstract

Albert Liu and colleagues report early experiences with uptake and delivery of pre-exposure prophylaxis(PrEP)for HIV prevention in three different settings in San Francisco. PrEP can be an important component of a comprehensive HIV prevention program and can complement efforts to increase HIV testing, linkage to care, and early initiation of antiretroviral therapy.

Please see later in the article for the Editors' Summary

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adenine / analogs & derivatives*
Adenine / therapeutic use
Anti-HIV Agents / therapeutic use*
Deoxycytidine / analogs & derivatives*
Deoxycytidine / therapeutic use
Disease Management*
Emtricitabine
Female
HIV Infections / drug therapy*
HIV Infections / prevention & control*
Humans
Male
Organophosphonates / therapeutic use*
San Francisco
Tenofovir

Substances

Anti-HIV Agents
Organophosphonates
Deoxycytidine
Tenofovir
Emtricitabine
Adenine

Abstract

Publication types

MeSH terms

Substances

Grants and funding